Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Power-TIL
- Development stage
- Unknown
- Lead developer
- Suzhou Lanma Medical Technology
- Modality
- Gene Silencing → Gene Therapies, Gene Editing → Gene Therapies, Tumor-Infiltrating Lymphocytes (TILs) → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies, Gene Addition/Replacement → Gene Therapies
- Administration
- Intravenous
01
Overview
Power-TIL is a platform of genetically modified tumor-infiltrating lymphocyte (TIL) cell therapies developed by Suzhou Lanma Medical Technology (Lanma Bio) for the treatment of solid tumors. Unlike conventional TIL therapies, the Power-TIL platform utilizes genetic engineering to enhance the anti-tumor activity, persistence, and expansion of T cells within the patient. By modifying the TILs, the developer aims to overcome the immunosuppressive tumor microenvironment that often limits the efficacy of non-modified cell therapies. The lead candidate in this series, LM303, is currently in the IND-enabling and Investigator-Initiated Trial (IIT) stages for various solid tumor indications. The specific genetic modifications, such as the addition of cytokines or the knockout of inhibitory receptors, have not been publicly disclosed in detail.
- Brand names
- Power-TIL
- Other names
- Power-TIL (other candidates)genetically modified tumor-infiltrating lymphocyte
02
Targets
pMHC (Peptide-MHC complex family)
Beyond the preview
Go deeper on Power-TIL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Power-TIL.